The differential pathways of bone morphogenetic protein (BMP)-4 and -7 in the suppression of the bovine granulosa cell apoptosis

Molecular and Cellular Biochemistry

Volumn 323, Issue 1-2, 2009, Pages 161-168

  Kayamori, Takefumi ^a   Kosaka, Naomichi ^a   Miyamoto, Akio ^a   Shimizu, Takashi ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Apoptosis; BMP 4; BMP 7; CAD; Caspase 3; Granulosa cell; Survivin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CASPASE 3; CASPASE 9; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CASPASE INHIBITOR; MESSENGER RNA; OSTEOGENIC PROTEIN 1; PROTEIN BAX; PROTEIN BCL XL; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; COW; ENZYME INHIBITION; FEMALE; GRANULOSA CELL; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; CASPASE 3; CASPASE 9; CATTLE; CELLS, CULTURED; DEOXYRIBONUCLEASES; FEMALE; GRANULOSA CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

BOVINAE; MAMMALIA;

EID: 59949089642     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9976-1     Document Type: Article

References (33)

1. Fortune JE (1994) Ovarian follicular growth and development in mammals. Biol Reprod 50:225-232. doi: 10.1095/biolreprod50.2.225
2. Shimasaki S, Moore RK, Otsuka F, Erickson GF (2004) The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25:72-101. doi: 10.1210/er.2003-0007
3. Erickson GF, Shimasaki S (2003) The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 1:9. doi: 10.1186/1477-7827-1-9
4. Shimizu T, Jayawardana BC, Nishimoto H, Kaneko E, Tetsuka M, Miyamoto A (2006) Involvement of the bone morphogenetic protein/receptor system during follicle development in the bovine ovary: Hormonal regulation of the expression of bone morphogenetic protein 7 (BMP-7) and its receptors (ActRII and Alk-2). Mol Cell Endocrinol 249:78-83
5. Shimizu T, Jayawardana BC, Nishimoto H, Kaneko E, Tetsuka M, Miyamoto A (2006) Hormonal regulation of expression of growth differentiation factor-9 receptor type I and II genes in the bovine ovarian follicle. Reproduction 131:545-553. doi: 10.1530/rep.1.00937
6. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF (1999) A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282-7287. doi: 10.1073/ pnas.96.13.7282
7. Lee W, Ostuka F, Moore RK, Shimasaki S (2001) The effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 65:994-999. doi: 10.1095/biolreprod65.4.994
8. Glister C, Kemp CF, Knight PG (2004) Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: Actions of BMP-4, -6 and -7 on granulose cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127:239-254. doi: 10.1530/rep.1.00090
9. Knight PG, Glister C (2006) TGF- superfamily members and ovarian follicle development. Reproduction 132:191-206. doi: 10.1530/rep.1.01074
10. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Ethier JF (2002) Recruitment and development of the follicle; the roles of the transforming growth factor-β superfamily. Mol Cell Endocrinol 191:35-43. doi: 10.1016/S0303-7207(02)00053-9
11. Nilsson EE, Skinner MK (2003) Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 69:1265-1272. doi: 10.1095/biolreprod.103.018671
12. Guthrie HD, Grimes RW, Cooper BS, Hammond JM (1995) Follicular atresia in pigs: Measurement and physiology. J Anim Sci 73:2834-2844
13. Hsueh AJ, Billig H, Tsafriri A (1994) Ovarian follicle atresia: A hormonally controlled apoptotic process. Endocr Rev 15:707-724. doi: 10.1210/er.15.6.707
14. Van Wezel IL, Dharmarajan AM, Lavranos TC, Rodgers RJ (1999) Evidence for alternative pathways of granulosa cell death in healthy and slightly atretic bovine antral follicles. Endocrinology 140:2602-2612. doi: 10.1210/en.140.6.2602
15. Zamzami N, Brenner C, Marzo I, Susin SA, Kroemer G (1998) Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16:2265-2282. doi: 10.1038/sj.onc.1201989
16. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, Nakane PK (1996) Fas/APO-1/CD95 system as a mediator of granulose cell apoptosis in ovarian follicle atresia. Endocrinology 137:1938-1948. doi: 10.1210/ en.137.5.1938
17. Guo MW, Xu JP, Mori E, Sato E, Saito S, Mori T (1997) Expression of Fas ligand in murine ovary. Am J Reprod Immunol 37:391-398
18. Porter DA, Harman RM, Cowan RG, Quirk SM (2001) Relationship of Fas ligand expression and atresia during bovine follicle development. Reproduction 121:561-566. doi: 10.1530/rep.0.1210561
19. Hussein TS, Froiland DA, Amato F, Thompson JG, Gilchrist RB (2005) Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci 118:5257-5268. doi: 10.1242/jcs.02644
20. Kroemer G (1997) Mode of action of the apoptosis-inhibitory proto-oncogene Bcl-2. Nat Med 3:614-620. doi: 10.1038/nm0697-614
21. Kosaka N, Sudo N, Miyamoto A, Shimizu T (2007) Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro. Biochem Biophys Res Commun 363:733-737. doi: 10.1016/ j.bbrc.2007.09.061
22. Deveraux QL, Reed JC (1999) IAP family proteins-suppressors of apoptosis. Genes Dev 13:239-252. doi: 10.1101/gad.13.3.239
23. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG (2000) Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70:113-122. doi: 10.1006/ geno.2000.6364
24. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG (2001) Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 3:128-133. doi: 10.1038/35055027
25. Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42. doi: 10.1016/S0092-8674(00)00008-8
26. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP protein. Cell 102:43-53. doi: 10.1016/S0092-8674(00)00009-X
27. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320
28. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD (1999) Survivin-deltaEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59:6097-6102
29. Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T, Inuzuka M (2004) Identification of a novel splice variant of the human anti-apoptosis gene surviving. Biochem Biophys Res Commun 314:902-907. doi: 10.1016/j.bbrc.2003.12.178
30. Caldas H, Honsey LE, Altura RE (2005) Survivin 2alpha: A novel Survivin splice variant expressed in human malignancies. Mol Cancer 4:11-98. doi: 10.1186/1476-4598-4-11
31. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y, Alnemri ES (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112-116. doi: 10.1038/35065125
32. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell death proteases. Nature 388:300-304. doi: 10.1038/40901
33. Lechardeur D, Dougaparsad S, Nemes C, Lukacs GL (2005) Oligomerization state of the DNA fragmentation factor in normal and apoptotic cells. J Biol Chem 280:40216-40225. doi: 10.1074/jbc.M502220200